These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy. Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237 [TBL] [Abstract][Full Text] [Related]
32. Biometric characteristics of eyes with central serous chorioretinopathy. Oh JH; Oh J; Togloom A; Kim SW; Huh K Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360 [TBL] [Abstract][Full Text] [Related]
33. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic and therapeutic challenges. Wong IY; Lam JK; Cebulla CM Retina; 2013 May; 33(5):1076-80. PubMed ID: 23296050 [No Abstract] [Full Text] [Related]
35. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY. Lee H; Lee J; Chung H; Kim HC Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841 [TBL] [Abstract][Full Text] [Related]
36. A novel marker in acute central serous chorioretinopathy: thiol/disulfide homeostasis. Altinkaynak H; Kurkcuoglu PZ; Caglayan M; Yorgun MA; Yuksel N; Kosekahya P; Koca C; Toklu Y Int Ophthalmol; 2018 Feb; 38(1):175-181. PubMed ID: 28108906 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and interventions for central serous chorioretinopathy: review and update. Quin G; Liew G; Ho IV; Gillies M; Fraser-Bell S Clin Exp Ophthalmol; 2013 Mar; 41(2):187-200. PubMed ID: 22788713 [TBL] [Abstract][Full Text] [Related]
38. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [TBL] [Abstract][Full Text] [Related]
39. Intraocular gnathostomiasis and central serous chorioretinopathy. Moynihan V; Bhikoo R; Tay-Kearney ML Clin Exp Ophthalmol; 2020 Sep; 48(7):1005-1007. PubMed ID: 32506596 [No Abstract] [Full Text] [Related]